Summary of findings: repaglinide vs insulin
Change in BMI · children over 12 and adults with CFRD
Summary of findings: repaglinide showed no clear difference in BMI (kg/m²) change from baseline compared with insulin (low certainty).
1 finding from 1 review
- Drug treatments for managing cystic fibrosis‐related diabetes 2020 · Cochrane Headline outcomes onlyMD 0.241 study · 45 participantsLow